Selling And Administration Expenses Alterar Data
Acadia Pharmaceuticals USD 97.89M 1.92M 2023-09
Acorda Therapeutics USD 21.82M 689K 2023-06
Agios Pharmaceuticals USD 25.82M 4.59M 2023-09
Alnylam Pharmaceuticals USD 199.18M 15.51M 2023-09
Arrowhead Research USD 26.78M 92K 2023-09
AstraZeneca USD 3.91B 194M 2023-09
Bluebird Bio USD 40.7M 354K 2023-09
Bristol-Myers Squibb USD 1.94B 24M 2023-09
Eli Lilly USD 1.8B 121.5M 2023-09
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Esperion Therapeutics USD 33.24M 719K 2023-09
Halozyme Therapeutics USD 35.27M 3.68M 2023-09
Heron Therapeutics USD 24.6M 11.84M 2023-09
Insmed USD 90.63M 6.19M 2023-09
J&J USD 5.4B 1.27B 2023-09
Lexicon Pharmaceuticals USD 32.23M 2.22M 2023-09
Ligand Pharmaceuticals USD 14.66M 3.37M 2023-09
Merck USD 2.46B 163M 2023-09
Minerva Neurosciences USD 2.64M 3.06K 2023-09
Moderna USD 442M 110M 2023-09
Pfizer USD 3.36B 216M 2023-09
PTC Therapeutics USD 80.89M 7.56M 2023-09
Takeda JPY 252.95B 4.84B 2023-09
Teva Pharmaceutical Industries USD 844M 66M 2023-09
Ultragenyx Pharmaceutical USD 74.92M 6.49M 2023-09
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06
Veracyte USD 40.68M 10.12M 2023-09



Vanda Pharmaceuticals Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.